SUVZ

Suvanza (SUVZ)

Market Closed
15 Dec, 20:00
OTC GREY OTC GREY
$
0. 00
0
0%
$
1.01M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
$ 0
Previous Close
Day Range
0 0
Year Range
0 0.05
Want to track SUVZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SUVZ closed today higher at $0, an increase of 0% from yesterday's close, completing a monthly increase of 0% or $0. Over the past 12 months, SUVZ stock lost -99.6%.
SUVZ is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC GREY (USD).

SUVZ Chart

Similar

Cynata Therapeutics Limited
$ 0.15
0%
Quantum Healthcare Ltd.
$ 0.02
0%
Hemostemix Inc.
$ 0.06
-9.43%
Koala Corporation
$ 0
0%
Verisante Technology Inc.
$ 0
0%

Suvanza (SUVZ) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Suvanza is listed on OTC GREY.

What is its stock symbol?

The ticker symbol is SUVZ.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 1.01M.

Has Suvanza ever had a stock split?

No, there has never been a stock split.

Suvanza Profile

Biotechnology Industry
Healthcare Sector
Dr. Nardo Zaias CEO
OTC GREY Exchange
- ISIN
United States Country
- Employees
- Last Dividend
19 Mar 2010 Last Split
- IPO Date

Overview

Suvanza Pharma, LLC is a pioneering force in the biotechnology sector, specializing in the development of advanced drug delivery systems specifically for dermatologic applications. Originally established under the name Hamilton PNG, the company underwent a significant rebranding to Suvanza Pharma, LLC in March 2010, marking a new chapter in its commitment to innovation in skin care and treatment. With its foundation laid in 2004 and headquartered in the vibrant area of Miami Beach, Florida, Suvanza Pharma stands at the forefront of research and development aimed at addressing complex dermatologic diseases through cutting-edge technologies.

Products and Services

  • RapiDerm - Skin Drug Delivery System

    An innovative technology developed by Suvanza Pharma, RapiDerm is designed to revolutionize the treatment of dermatologic conditions. This proprietary skin drug delivery system facilitates the rapid and effective absorption of medications directly through the skin, offering a promising solution for patients suffering from a variety of skin diseases. By leveraging the unique properties of RapiDerm, Suvanza Pharma aims to improve therapeutic outcomes and enhance the quality of life for individuals dealing with challenging skin conditions.

Contact Information

Address: 5401 Collins Avenue
Phone: 866-633-9546